Legal & General Group’s Gyre Therapeutics GYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1K | Buy |
1,513
+910
| +151% | +$6.68K | ﹤0.01% | 3254 |
|
|
2025
Q1 | $4.64K | Hold |
603
| – | – | ﹤0.01% | 3286 |
|
|
2024
Q4 | $7.29K | Hold |
603
| – | – | ﹤0.01% | 3302 |
|
|
2024
Q3 | $7.62K | Hold |
603
| – | – | ﹤0.01% | 3319 |
|
|
2024
Q2 | $7.13K | Buy |
+603
| New | +$7.13K | ﹤0.01% | 3351 |
|
|
2021
Q2 | – | Sell |
-2,718
| Closed | -$14K | – | 3567 |
|
|
2021
Q1 | $14K | Buy |
2,718
+671
| +33% | +$3.46K | ﹤0.01% | 3277 |
|
|
2020
Q4 | $13K | Hold |
2,047
| – | – | ﹤0.01% | 3244 |
|
|
2020
Q3 | $9K | Sell |
2,047
-139
| -6% | -$611 | ﹤0.01% | 3265 |
|
|
2020
Q2 | $13K | Buy |
+2,186
| New | +$13K | ﹤0.01% | 3237 |
|
|
2019
Q3 | – | Sell |
-1,772
| Closed | -$13K | – | 3381 |
|
|
2019
Q2 | $13K | Hold |
1,772
| – | – | ﹤0.01% | 3311 |
|
|
2019
Q1 | $14K | Hold |
1,772
| – | – | ﹤0.01% | 3190 |
|
|
2018
Q4 | $14K | Hold |
1,772
| – | – | ﹤0.01% | 3202 |
|
|
2018
Q3 | $19K | Hold |
1,772
| – | – | ﹤0.01% | 3218 |
|
|
2018
Q2 | $21K | Buy |
+1,772
| New | +$21K | ﹤0.01% | 3174 |
|